Guangdong Runhe Biotechnology Co., Ltd.

Guangdong Runhe Biotechnology Co., Ltd. (hereinafter referred to as "Runhe Biotechnology") was established in 2001, headquartered in Guangzhou, Guangdong. It is one of the first enterprises in the industry to achieve a full industry chain coverage of "science, industry, trade, and tourism," committed to developing health products suitable for the Chinese constitution.
In 2001, starting with the agency of high-end American biological products, it introduced Coenzyme Q10 products to China. In 2009, Runhe Biotechnology continuously introduced industry R&D elites, actively conducted research and innovation, and successfully launched its self-developed product "*Generation Coenzyme Q10 Cell Power." In 2011, it launched its self-developed product Puyuan Brand Coenzyme Q10, which obtained the national Blue Hat approval. In 2017, Runhe Biotechnology achieved integrated full industry chain coverage of "science, industry, trade, and tourism" including R&D, production, sales, and cultural tourism. Its product Puyuan Coenzyme Q10 was awarded the honor of "High-tech Product." In 2018, Runhe Biotechnology, with core competitiveness from technological and model innovation, was rated as "High-tech Enterprise" and "Technological Innovation Small Giant Enterprise." In 2019, Runhe Biotechnology obtained a pharmaceutical invention patent and was rated as "Guangdong Province Contract-honoring and Credit-worthy Enterprise" by the Guangzhou Municipal Administration for Market Regulation for three consecutive years.